Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ELSEVIER SCIENCE INC

1. National Institute for Health Research Career Development Fellowship [CDF-2015-08-074]
2. Boehringer Ingelheim
3. Bayer
4. Bristol-Myers Squibb/Pfizer
5. Daiichi-Sankyo
6. Merck
7. Novartis
8. Roche
9. Lilly
10. European Union
11. British Heart Foundation
12. Leducq Foundation
13. Medical Research Council (U.K.)
14. German Centre for Cardiovascular Research
15. 3M Medica
16. MEDA Pharma
17. AstraZeneca
18. Bayer HealthCare
19. Biosense Webster
20. German Cardiac Society
21. Medtronic
22. Merck Sharp Dohme
23. Otsuka Pharma
24. Sanofi
25. Servier
26. Siemens
27. Takeda